Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-κB interaction in activated microglia

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1181-1185

  Delgado, Mario ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CBP; CREB; Inflammation; Microglia; Neuroimmunomodulation; Neuropeptides; NF B

Indexed keywords

DNA; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPEPTIDE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; INFLAMMATION; MICROGLIA; PHOSPHORYLATION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CREB-BINDING PROTEIN; CYCLIC AMP; INFLAMMATION; MICE; MICROGLIA; NEUROPEPTIDES; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PRECIPITIN TESTS; PROTEIN BINDING; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036401238     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02305-7     Document Type: Article

References (35)

1. F. Gonzalez-Scarano, G. Baltuch, Microglia as mediators of inflammatory and degenerative diseases, Annu. Rev. Neurosci. 22 (1999) 219-240.
2. A. Baldwin, The NF-κB and IκB proteins: new discoveries and insights, Annu. Rev. Immunol. 14 (1996) 649-681.
3. M. Karin, Y. Ben-Neriah, Phosphorylation meets ubiquitination: the control of NF-[κ]B activity, Annu. Rev. Immunol. 18 (2000) 621-664.
4. P.S. Goldman, V.K. Tran, R.H. Goldman, The multifunctional role of the co-activator CBP in transcriptional regulation, Recent Prog. Horm. Res. 52 (1997) 103-119.
5. R. Janknecht, T. Hunter, Versatile molecular glue. Transcriptional control, Curr. Biol. 6 (1996) 951-954.
6. Y. Kamei, L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C Lin, R. Heyman, D. Rose, C. Glass, M. Rosenfeld, A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors, Cell 85 (1996) 403-414.
7. R.P. Kwok, J.R. Lundblad, J.C. Chrivia, J.P. Richards, H.P. Bachinger, R.G. Brennan, S.G.E. Roberts, M.R. Green, R.H. Goodman, Nuclear protein CBP is a coactivator for the transcription factor CREB, Nature 370 (1994) 223-226.
8. J.-S. Lee, R.H. See, T. Deng, Y. Shi, Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300, Mol. Cell. Biol. 16 (1996) 4312-4326.
9. H. Zhong, R.E. Voll, R. Ghosh, Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300, Mol. Cell 1 (1998) 661-671.
10. M.E. Gerritsen, A.J. Williams, A.S. Neish, S. Moore, Y. Shi, T. Collins, CREB-binding protein/p300 are transcriptional coactivators of p65, Proc. Natl. Acad. Sci. USA 94 (1997) 2927-2932.
11. G.C. Parry, N. Mackman, Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription, J. Immunol. 159 (1997) 5450-5456.
12. H. Zhong, H. SuYang, H. Erdjument-Bromage, P. Tempst, S. Ghosh, The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism, Cell 89 (1997) 413-424.
13. J.C. Chrivia, R.P.S. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, R.H. Goodman, Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature 365 (1993) 855-859.
14. J. Arias, A.S. Alberts, P. Brindle, F.X. Claret, T. Smeal, M. Karin, J. Feramisco, M. Montminy, Activation of cAMP and mitogen responsive genes relies on a common nuclear factor, Nature 370 (1994) 226-229.
15. A.J. Bannister, T. Kouzarides, CBP-induced stimulation of c-Fos activity is abrogated by E1A, EMBO J. 14 (1995) 4758-4762.
16. J. Lundblad, R. Kwok, M. Laurance, M. Harter, R.H. Goodman, Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP, Nature 374 (1995) 85-88.
17. P. Dai, H. Akimaru, Y. Tanaka, D.-X. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, S. Ishii, CBP as a transcriptional coactivator of c-Myb, Genes Dev. 10 (1996) 528-540.
18. R.P. Gomariz, C. Martinez, C. Abad, J. Leceta, M. Delgado, Immunology of VIP: a review and therapeutical perspectives, Curr. Pharm. Design 7 (2001) 89-111.
19. M. Delgado, D. Pozo, C. Martinez, J. Leceta, J.R. Calvo, D. Ganea, R.P. Gomariz, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNFα production by macrophages: in vitro and in vivo studies, J. Immunol. 162 (1999) 2358-2367.
20. M. Delgado, E.J. Munoz-Elias, Y. Kan, I. Gozes, M. Fridkin, D.E. Brenneman, R.P. Gomariz, D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun, J. Biol. Chem. 273 (1998) 31427-31436.
21. M. Delgado, E.J. Munoz-Elias, R.P. Gomariz, D. Ganea, VIP and PACAP prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and interferon regulatory factor 1 activation, J. Immunol. 162 (1999) 4685-4696.
22. M. Delgado, E.J. Munoz-Elias, R.P. Gomariz, D. Ganea, VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T Cells, J. Neuroimmunol. 96 (1999) 167-181.
23. M. Delgado, D. Ganea, Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo, J. Immunol. 167 (2001) 966-975.
24. M. Delgado, G.M. Jonakait, D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia, Glia 39 (2002) 148-161.
25. M. Delgado, J. Leceta, D. Ganea. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J. Leukoc. Biol. (2002) in press.
26. M. Delgado, C. Martinez, D. Pozo, J.R. Calvo, J. Leceta, D. Ganea, R.P. Gomariz, VIP and PACAP protect mice from lethal endotoxemia through the inhibition of TNFα and IL-6, J. Immunol. 162 (1999) 1200-1205.
27. S.I. Said, Molecules that protect: the defense of neurons and other cells, J. Clin. Invest. 97 (1996) 99-103.
28. C.C. Chao, T.W. Molitor, H. Shuxian, Neuroprotective role of IL-4 against activated microglia, J. Immunol. 151 (1993) 1473-1481.
29. J.A. Shumilla, R.J. Broderick, Y. Wang, A. Barchowsky, Chromium(VI) inhibits the transcriptional activity of nuclear factor-κB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein, J. Biol. Chem. 274 (1999) 36207-36212.
30. M. Delgado, D. Ganea, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-κB-dependent gene activation at multiple levels in the human monocytic cell line THP-1, J. Biol. Chem. 276 (2001) 369-380.
31. A.J. Harmar, A. Arimura, I. Gozes, L. Journot, M. Laburthe, J.R. Pisegna, S.R. Rawlings, P. Robberecht, S.I. Said, S.P. Sreedharan, S.A. Wank, J.A. Washeck, A. Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP), Pharmacol. Rev. 50 (1998) 625-627.
32. W. Kim, Y. Kan, D. Ganea, R.P. Hart, I. Gozes, G.M. Jonakait, Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor-α production in injured spinal cord and in activated microglia via a cAMP-dependent pathway, J. Neurosci. 20 (2000) 3622-3630.
33. P. Gourlet, A. Vandermeers, P. Vertongen, J. Ratche, P. De Neef, J. Cnudde, M. Waelbroeck, P. Robberecht, Development of high affinity selective VIP1 receptor agonists, Peptides 18 (1996) 1539-1545.
34. P. Gourlet, P. De Neef, J. Cnudde, M. Waelbroeck, P. Robberecht, In vitro properties of a high affinity selective antagonist of the VIP1 receptor, Peptides 18 (1997) 1555-1560.
35. M. Xia, S.P. Sreedharan, D.R. Bolin, G.O. Gaufo, E.J. Goetzl, Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor, J. Pharmacol. Exp. Ther. 281 (1997) 629-633.